181 related articles for article (PubMed ID: 3319661)
1. Ceftazidime treatment of chronic Pseudomonas infection in patients with cystic fibrosis.
Fluge G; Digranes A; Michalsen H; Stiris T; Bergan T; Qvigstad EK
Eur J Respir Dis; 1987 Oct; 71(4):239-43. PubMed ID: 3319661
[TBL] [Abstract][Full Text] [Related]
2. Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience.
Hansen CR; Pressler T; Høiby N
J Cyst Fibros; 2008 Nov; 7(6):523-30. PubMed ID: 18693078
[TBL] [Abstract][Full Text] [Related]
3. [Continuous intravenous home treatment of airway infections using ceftazidime administration via portable pump in patients with cystic fibrosis; a multicenter study].
Bakker W; Vinks AA; Mouton JW; de Jonge P; Verzijl JG; Heijerman HG
Ned Tijdschr Geneeskd; 1993 Nov; 137(48):2486-91. PubMed ID: 8272124
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients.
Cantón R; Cobos N; de Gracia J; Baquero F; Honorato J; Gartner S; Alvarez A; Salcedo A; Oliver A; García-Quetglas E;
Clin Microbiol Infect; 2005 Sep; 11(9):690-703. PubMed ID: 16104983
[TBL] [Abstract][Full Text] [Related]
5. Long-term tobramycin aerosol therapy of chronic Pseudomonas aeruginosa infection in patients with cystic fibrosis.
Gappa M; Steinkamp G; Tümmler B; von der Hardt H
Scand J Gastroenterol Suppl; 1988; 143():74-6. PubMed ID: 3164515
[TBL] [Abstract][Full Text] [Related]
6. Azlocillin in cystic fibrosis.
Malmborg AS; Alfredsson H; Strandvik B
Isr J Med Sci; 1983 Nov; 19(11):1001-3. PubMed ID: 6662681
[TBL] [Abstract][Full Text] [Related]
7. Azlocillin and gentamicin in respiratory tract infections with Pseudomonas aeruginosa in patients with cystic fibrosis.
Malmborg AS; Alfredsson H; Kusoffsky E; Strandvik B
Scand J Infect Dis Suppl; 1981; 29():64-9. PubMed ID: 6947407
[TBL] [Abstract][Full Text] [Related]
8. Antibiotic treatment of chronic Pseudomonas aeruginosa infection in cystic fibrosis patients.
Møller NE; Høiby N
Scand J Infect Dis Suppl; 1981; 29():87-91. PubMed ID: 6458884
[TBL] [Abstract][Full Text] [Related]
9. Amikacin therapy of exacerbations of Pseudomonas aeruginosa infections in patients with cystic fibrosis.
Lau WK; Young LS; Osher AB; Dooley RR
Pediatrics; 1977 Sep; 60(3):372-7. PubMed ID: 408787
[TBL] [Abstract][Full Text] [Related]
10. Experience with ceftazidime in cystic fibrosis.
Dodge J; Zamiri I; Goodchild M; Ingram P
J Antimicrob Chemother; 1983 Jul; 12 Suppl A():325-9. PubMed ID: 6352637
[TBL] [Abstract][Full Text] [Related]
11. Ceftazidime in cystic fibrosis: clinical, microbiological and immunological studies.
Cullen RT; McCrae WM; Govan J; Raeburn JA; Ingram TM
J Antimicrob Chemother; 1983 Jul; 12 Suppl A():369-75. PubMed ID: 6352647
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of pyocyanic bacillus superinfections in children with cystic fibrosis using a new cephalosporin: ceftazidime].
Labbé A; Sablayrolles B; Dechamps C; Sirot J; Marty N
Ann Pediatr (Paris); 1986 Sep; 33(7):625-8. PubMed ID: 3096185
[No Abstract] [Full Text] [Related]
13. Eradication of initial Pseudomonas aeruginosa colonization in patients with cystic fibrosis.
Griese M; Müller I; Reinhardt D
Eur J Med Res; 2002 Feb; 7(2):79-80. PubMed ID: 11891148
[TBL] [Abstract][Full Text] [Related]
14. The treatment of pulmonary infection in cystic fibrosis.
Webb AK
Scand J Infect Dis Suppl; 1995; 96():24-7. PubMed ID: 7652499
[TBL] [Abstract][Full Text] [Related]
15. Ceftazidime treatment of chronic Pseudomonas aeruginosa respiratory tract infection in cystic fibrosis.
Permin H; Koch C; Høiby N; Christensen HO; Møller AF; Møller S
J Antimicrob Chemother; 1983 Jul; 12 Suppl A():313-23. PubMed ID: 6352636
[TBL] [Abstract][Full Text] [Related]
16. Clinical results and pharmacokinetics of ceftazidime treatment in patients with cystic fibrosis.
Strandvik B; Malmborg AS; Alfredson H; Ericsson A
J Antimicrob Chemother; 1983 Jul; 12 Suppl A():283-7. PubMed ID: 6352633
[TBL] [Abstract][Full Text] [Related]
17. Changes in lung function in young cystic fibrosis patients between two courses of intravenous antibiotics against Pseudomonas aeruginosa.
Béghin L; Michaud L; Loeuille GA; Wizla-Derambure N; Sayah H; Sardet A; Thumerelle C; Deschildre A; Turck D; Gottrand F
Pediatr Pulmonol; 2009 May; 44(5):464-71. PubMed ID: 19360849
[TBL] [Abstract][Full Text] [Related]
18. Differences in prevalence and treatment of Pseudomonas aeruginosa in cystic fibrosis centres in Denmark, Norway and Sweden.
Knudsen PK; Olesen HV; Høiby N; Johannesson M; Karpati F; Laerum BN; Meyer P; Pressler T; Lindblad A;
J Cyst Fibros; 2009 Mar; 8(2):135-42. PubMed ID: 19157995
[TBL] [Abstract][Full Text] [Related]
19. Alternative antibiotics for the treatment of Pseudomonas infections in cystic fibrosis.
Mastella G; Agostini M; Barlocco G; Bonomi U; Borgo G; Bozzino L; Cabrini G; Cappelletti LM; Castellani L; Conforti M
J Antimicrob Chemother; 1983 Jul; 12 Suppl A():297-311. PubMed ID: 6311788
[TBL] [Abstract][Full Text] [Related]
20. [Multicenter clinical study and pharmacokinetics of ceftazidime in children and newborn infants].
Bégué P; Michel B; Chasalette JP; Allouche G; Quinet B
Pathol Biol (Paris); 1986 May; 34(5):525-9. PubMed ID: 3534737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
